Day profile of insulin secretion rates in patients with type 2 diabetes treated using medium and long-acting sulphonylurea agents

被引：0
|
作者：
Luzio, S
Cozma, L
Dunseath, G
Peter, R
Pauvaday, V
Owens, D
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A451 / A451
页数：1
相关论文
共 50 条
  • [1] Assess the efficacy differences of using long-acting insulin and oral hypoglycemic agents in type 2 diabetes patients
    Chen, Chiu-Ju
    Su, Hui-Chen
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S98 - S98
  • [2] Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes
    Edith M. Heintjes
    Trine L. Thomsen
    Fernie J. A. Penning-van Beest
    Torsten E. Christensen
    Ron M. C. Herings
    [J]. Advances in Therapy, 2010, 27 : 211 - 222
  • [3] Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Aktas, Gulali
    Taslamacioglu Duman, Tuba
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2024, 19 (02) : 155 - 161
  • [4] Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Duman, Tuba Taslamacioglu
    Aktas, Gulali
    Tel, Burcin Meryem Atak
    Bilgin, Satilmis
    Kahveci, Gizem
    Kurtkulagi, Ozge
    [J]. JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2023, 31 (12): : 2039 - 2044
  • [5] Glycemic Control and Long-Acting Insulin Analog Utilization in Patients with Type 2 Diabetes
    Heintjes, Edith M.
    Thomsen, Trine L.
    Penning-van Beest, Fernie J. A.
    Christensen, Torsten E.
    Herings, Ron M. C.
    [J]. ADVANCES IN THERAPY, 2010, 27 (04) : 211 - 222
  • [6] Effect of Dulaglutide and Long-Acting Insulin Combination Therapy in Patients with Type 2 Diabetes
    Ito, Kohei
    Kondo, Yoshinobu
    Satoh, Shinobu
    Terauchi, Yasuo
    [J]. DIABETES, 2018, 67
  • [7] Evaluation of the effectiveness of long-acting insulin analogs in patients with type 2 diabetes mellitus
    Tuba Taslamacioglu Duman
    Gulali Aktas
    Burcin Meryem Atak Tel
    Satilmis Bilgin
    Gizem Kahveci
    Ozge Kurtkulagi
    [J]. Journal of Public Health, 2023, 31 : 2039 - 2044
  • [8] The utilisation of long-acting insulin analogues and intermediate-acting insulin in patients with type 2 diabetes in the United Kingdom
    Brunetti, V. C.
    Yu, O. H. Y.
    Platt, R. W.
    Filion, K. B.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S146 - S146
  • [9] Type 2 diabetes: Which long-acting insulin should be preferred?
    Nauck, Michael
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (34-35) : 1678 - 1678
  • [10] Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes
    Schmid, C.
    Krayenbuhl, P.
    Wiesli, P.
    [J]. DIABETOLOGIA, 2009, 52 (12) : 2668 - 2669
12345